Qiagen NV News

QIAGEN Gets FDA Clearance for QIAstat-Dx Respiratory Panel Plus

Seeking Alpha02:06

QIAGEN (QGEN) to Enhance Forensics With New Partnership

QIAGEN N.V. QGEN recently entered into a cooperative research and development agreement (CRADA) with the Federal Bureau of Investigation (FBI).

Yahoo Finance00:22

Qiagen's (NYSE:QGEN) Investors Will Be Pleased With Their 15% Return Over the Last Five Years

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, wh

Simply Wall StMay 13 20:33

Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel

Qiagen (QIA.F) on Monday said the US Food and Drug Administration authorized its QIAstat-Dx respiratory syndromic testing panel for clinical use. The molecular testing company's QIAstat-Dx Respiratory

MT NewswiresMay 13 14:54

QIAGEN Partners With FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics

Collaboration aims to create novel digital PCR assay to improve successful results in DNA analysis from human samples for use in forensics and human identification // DNA quantification enables law en

GlobeNewswireMay 8 04:05

Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report

Earnings reports and a dovish stance from the Federal Reserve lifted stocks last week. Major indices reacted positively, particularly to earnings from high-profile companies that hold significant weig

BenzingaMay 6 17:25

QIAGEN Enhances Bioinformatics Workflows With New Secondary Analysis Solution for Oncology and Inherited Disease Applications

QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data // New software advances p

GlobeNewswireMay 3 04:05

Qiagen Is Maintained at Hold by Stifel

Qiagen Is Maintained at Hold by Stifel

Dow JonesMay 1 21:33

Stifel Maintains Hold on Qiagen, Lowers Price Target to $45

Stifel analyst Daniel Arias maintains Qiagen with a Hold and lowers the price target from $55 to $45.

Analyst UpgradesMay 1 21:23

Qiagen Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 6.31% Stifel $55 → $45 Maintains Hold 02/16/2024 20.48% Morgan Stanley $49.48 → $51 Upgrades Eq

BenzingaMay 1 21:22

Earnings Call Summary | Qiagen NV(QGEN.US) Q1 2024 Earnings Conference

The following is a summary of the Qiagen N.V. (QGEN) Q1 2024 Earnings Call Transcript:Financial Performance:Qiagen reported Q1 2024 net sales of $462 million at constant exchange rates, an improvement

Futu NewsMay 1 08:39 · Conference Call

Deutsche Bank Remains a Buy on Qiagen (QGEN)

TipRanksApr 30 21:36

UBS Sticks to Its Hold Rating for Qiagen (QGEN)

TipRanksApr 30 13:35

Qiagen Shares Tumble on Lowered Guidance Despite Q1 Beat

Qiagen N.V. (NYSE: NYSE:QGEN) reported first-quarter earnings that edged past analysts' expectations but provided a full-year outlook that fell short of consensus estimates, prompting a 7.84% slide in its shares.

Investing.com Apr 30 04:54

Qiagen Q1 Adjusted Earnings, Sales Decline; Q2 Outlook Issued, 2024 Guidance Affirms -- Shares Fall After Hours

Qiagen (QGEN) reported Q1 adjusted earnings Monday of $0.46 per diluted share, down from $0.51 per share a year earlier. Analysts polled by Capital IQ expected $0.44. Net sales for the quarter ended M

MT NewswiresApr 30 04:48

QIAGEN Reaffirms FY24 Adj. EPS $2.10 Vs $2.11 Est.; Net Sales $2.0B Vs $2.010B Est.

QIAGEN Reaffirms FY24 Adj. EPS $2.10 Vs $2.11 Est.; Net Sales $2.0B Vs $2.010B Est.

BenzingaApr 30 04:29

Qiagen Q1 2024 Adj EPS $0.46 Beats $0.44 Estimate, Sales $458.796M Beat $457.330M Estimate

Qiagen (NYSE:QGEN) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.44 by 4.55 percent. This is a 9.8 percent decrease over earnings of $0.51 per share fr

BenzingaApr 30 04:11

QIAGEN Reports Results for Q1 2024 Ahead of Outlook, on Track to Achieve Full-year 2024 Guidance

Venlo, the Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE:QGEN, Frankfurt Prime Standard: QIA)) today announced results for the first quarter of 2024. Net sales declined 5% to $459 million, while

GlobeNewswireApr 30 04:05

Qiagen Q1 2024 Earnings Preview

Seeking AlphaApr 29 05:35

Investors Interested In Qiagen N.V.'s (NYSE:QGEN) Earnings

Qiagen N.V.'s (NYSE:QGEN) price-to-earnings (or "P/E") ratio of 26.9x might make it look like a strong sell right now compared to the market in the United States, where around half of the companies ha

Simply Wall StApr 25 19:08